Intragraft cytomegalovirus protein expression is associated with reduced renal allograft survival

Clinical Infectious Diseases

Volumn 53, Issue 10, 2011, Pages 969-976

  Dzabic, Mensur ^a   Rahbar, Afsar ^a   Yaiw, Koon Chu ^a   Naghibi, Mansour ^b   Religa, Piotr ^a   Fellström, Bengt ^b   Larsson, Erik ^b   Söderberg Nauclér, Cecilia ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DNA; INTRAGRAFT CYTOMEGALOVIRUS PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ADULT; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CYTOMEGALOVIRUS; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVIEW; SURVIVAL; SURVIVAL TIME;

ADULT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; TRANSPLANTATION, HOMOLOGOUS; VIRAL PROTEINS;

EID: 80054764794     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir619     Document Type: Review

References (37)

1. Mocarski ES Jr., Courcelle, CT. Cytomegaloviruses and their replication. In: Knipe DM, Howley PM, eds. Fields Virology. 4th ed. Philadelphia, Pennsylvania: Lippincott Williams & Wilkins, 2001: 2629-73.
2. Söderberg-Nauclér C, Fish KN, Nelson JA. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997; 91:119-26. (Pubitemid 27431318)
3. Reeves MB, Macary PA, Lehner PJ, Sissons JG, Sinclair JH. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proceedings of the National Academy Sciences USA 2005; 102:4140-4145. (Pubitemid 40388569)
4. Söderberg-Nauclér C. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med 2006; 259:219-46.
5. Murphy E, Yu D, Grimwood J, et al. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A 2003; 100:14976-81. (Pubitemid 37518002)
6. Qiu H, Strååt K, Rahbar A, Wan M, Söderberg- Nauclér C, Haeggström JZ. Human CMV infection induces 5-lipoxygenase expression and leukotriene B4 production in vascular smooth muscle cells. J Exp Med 2008; 205:19-24. (Pubitemid 351185711)
7. Slinger E, Maussang D, Schreiber A, et al. HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci Signal 2010; 3:ra58.
8. Streblow DN, Söderberg-Nauclér C, Vieira J, et al. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 1999; 99:511-20.
9. Streblow DN, Kreklywich CN, Smith P, et al. Rat cytomegalovirusaccelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33. Am J Transplant 2005; 5:436-42. (Pubitemid 40313334)
10. Fishman JA. Infection in renal transplant recipients. Semin Nephrol 2007; 27:445-61. (Pubitemid 47009007)
11. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357:2601-14. (Pubitemid 350294226)
12. Racusen LC, Regele H. The pathology of chronic allograft dysfunction. Kidney Int Suppl 2010; 78:S27-32.
13. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349:2326-33. (Pubitemid 37509740)
14. Mengel M, Gwinner W, Schwarz A, et al. Infiltrates in protocol biopsies from renal allografts. Am J Transplant 2007; 7:356-65. (Pubitemid 46096328)
15. Helanterä I, Koskinen P, Finne P, et al. Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival. Transpl Int 2006; 19:893-900. (Pubitemid 44511113)
16. Solá R, Díaz JM, Guirado L, et al. Significance of cytomegalovirus infection in renal transplantation. Transplant Proc 2003; 35:1753-5. (Pubitemid 37093698)
17. Streblow DN, Orloff SL, Nelson JA. Acceleration of allograft failure by cytomegalovirus. Curr Opin Immunol 2007; 19:577-82. (Pubitemid 47464920)
18. Cainelli F, Vento S. Infections and solid organ transplant rejection: A cause-and-effect relationship? Lancet Infect Dis 2002; 2:539-49. (Pubitemid 34966357)
19. Smith SR, Butterly DW, Alexander BD, Greenberg A. Viral infections after renal transplantation. Am J Kidney Dis 2001; 37:659-76. (Pubitemid 32268027)
20. Yang CW, Kim YO, Kim YS, et al. Clinical course of cytomegalovirus (CMV) viremia with and without ganciclovir treatment in CMVseropositive kidney transplant recipients: Longitudinal follow-up of CMV pp65 antigenemia assay. Am J Nephrol 1998; 18:373-8. (Pubitemid 28442098)
21. Hartmann A, Sagedal S, Hjelmesaeth J. The natural course of cytomegalovirus infection and disease in renal transplant recipients. Transplantation 2006; 82:S15-7. (Pubitemid 44126861)
22. Ustinov JA, Loginov RJ, Mattila PM, et al. Cytomegalovirus infection of human kidney cells in vitro. Kidney Int 1991; 40:954-60.
23. Rubin RH. The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: The end of the 'silo hypothesis'. Curr Opin Infect Dis 2007; 20:399-407. (Pubitemid 47026238)
24. Gerstenkorn C, Robertson H, Mohamed MA, O'Donnell M, Ali S, Talbot D. Detection of cytomegalovirus (CMV) antigens in kidney biopsies and transplant nephrectomies as a marker for renal graft dysfunction. Clin Chem Lab Med 2000; 38:1201-3. (Pubitemid 32007781)
25. Li YT, Emery VC, Surah S, et al. Extensive human cytomegalovirus (HCMV) genomic DNA in the renal tubular epithelium early after renal transplantation: Relationship with HCMV DNAemia and longterm graft function. J Med Virol 2009; 82:85-93.
26. Freeman RB Jr. The 'indirect' effects of cytomegalovirus infection. Am J Transplant 2009; 9:2453-8.
27. Rubin RH. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. JAMA 1989; 261:3607-9.
28. Tolkoff-Rubin NE, Fishman JA, Rubin RH. The bidirectional relationship between cytomegalovirus and allograft injury. Transplant Proc 2001; 33:1773-5. (Pubitemid 32238059)
29. Lu DY, Qian J, Easley KA, Waldrop SM, Cohen C. Automated in situ hybridization and immunohistochemistry for cytomegalovirus detection in paraffin-embedded tissue sections. Appl Immunohistochem Mol Morphol 2009; 17:158-64.
30. Rimsza LM, Vela EE, Frutiger YM, et al. Rapid automated combined in situ hybridization and immunohistochemistry for sensitive detection of cytomegalovirus in paraffin-embedded tissue biopsies. Am J Clin Pathol 1996; 106:544-8. (Pubitemid 26333007)
31. Söderberg-Nauclér C. HCMV microinfections in inflammatory diseases and cancer. J Clin Virol 2008; 41:218-23.
32. Mitchell DA, Xie W, Schmittling R, et al. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol 2008; 10:10-8. (Pubitemid 351250896)
33. Cobbs CS, Harkins L, Samanta M, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 2002; 62:3347-50. (Pubitemid 34651375)
34. Harkins L, Volk AL, Samanta M, et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 2002; 360:1557-63. (Pubitemid 35356371)
35. Harkins LE, Matlaf AL, Soroceanu L, et al. Detection of human cytomegalovirus in normal and neoplastic breast epithelium. Herpesviridae 2010; 1:8.
36. Eyzaguirre E, Haque AK. Application of immunohistochemistry to infections. Arch Pathol Lab Med 2008; 132:424-31. (Pubitemid 351337536)
37. Chapman TM, Keating GM. Basiliximab: A review of its use as induction therapy in renal transplantation. Drugs 2003; 63:2803-35. (Pubitemid 38049995)